LOADING
Comparing AbbVie Inc (ABBV) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | KO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $380.6B | $337.4B |
| P/E Ratio | 105.1 | 24.7 |
| Forward P/E | 14.9 | 24.1 |
| PEG Ratio | 0.59 | 4.03 |
| EPS | $2.05 | $3.18 |
| Revenue Growth (YoY) | 12.4% | 12.1% |
| Profit Margin | 5.8% | 27.8% |
| Return on Equity | 62.3% | 43.4% |
| Dividend Yield | 3.17% | 2.62% |
| Beta | 0.30 | 0.36 |
| 52-Week High | $239.13 | $82.66 |
| 52-Week Low | $176.00 | $64.45 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.